Voloridge Investment Management, LLC Corcept Therapeutics Inc Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

A detailed history of Voloridge Investment Management, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 622,171 shares of CORT stock, worth $34.1 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

622,171

Previous 769,414 19.14%

Holding current value

$34.1 Million

Previous $25 Million 15.13%

% of portfolio

0.11%

Previous 0.1%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$29.51 - $46.26 $4.35 Million - $6.81 Million	-147,243 Reduced 19.14%	622,171 $28.8 Million
Q2 2024 Aug 14, 2024	SELL	$22.21 - $34.48 $5.86 Million - $9.1 Million	-263,811 Reduced 25.53%	769,414 $25 Million
Q1 2024 May 15, 2024	BUY	$21.1 - $27.46 $10.3 Million - $13.3 Million	485,928 Added 88.79%	1,033,225 $26 Million
Q4 2023 Feb 14, 2024	BUY	$24.82 - $32.88 $2.81 Million - $3.72 Million	113,273 Added 26.1%	547,297 $17.8 Million
Q3 2023 Nov 14, 2023	BUY	$21.97 - $33.8 $8.76 Million - $13.5 Million	398,787 Added 1131.73%	434,024 $11.8 Million
Q2 2023 Aug 14, 2023	SELL	$21.44 - $25.15 $624,825 - $732,946	-29,143 Reduced 45.27%	35,237 $784,000
Q1 2023 May 15, 2023	SELL	$19.2 - $24.47 $37,459 - $47,740	-1,951 Reduced 2.94%	64,380 $1.39 Million
Q4 2022 Feb 14, 2023	SELL	$19.95 - $29.96 $3.5 Million - $5.26 Million	-175,642 Reduced 72.59%	66,331 $1.35 Million
Q3 2022 Nov 14, 2022	SELL	$24.7 - $29.12 $1.75 Million - $2.06 Million	-70,870 Reduced 22.65%	241,973 $6.2 Million
Q2 2022 Aug 15, 2022	SELL	$17.33 - $25.3 $1.27 Million - $1.86 Million	-73,406 Reduced 19.0%	312,843 $7.44 Million
Q1 2022 May 16, 2022	BUY	$16.53 - $25.21 $5.26 Million - $8.03 Million	318,425 Added 469.49%	386,249 $8.7 Million
Q4 2021 Feb 14, 2022	BUY	$17.1 - $23.34 $1.16 Million - $1.58 Million	67,824 New	67,824 $1.34 Million
Q2 2021 Aug 16, 2021	SELL	$19.97 - $24.43 $1.28 Million - $1.57 Million	-64,270 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$23.49 - $30.56 $3.97 Million - $5.17 Million	-169,135 Reduced 72.46%	64,270 $1.53 Million
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $2.01 Million - $3.26 Million	-119,498 Reduced 33.86%	233,405 $6.11 Million
Q3 2020 Nov 16, 2020	BUY	$12.46 - $19.98 $2.63 Million - $4.22 Million	211,385 Added 149.37%	352,903 $6.14 Million
Q2 2020 Aug 14, 2020	BUY	$11.0 - $18.26 $189,167 - $314,017	17,197 Added 13.83%	141,518 $2.38 Million
Q1 2020 May 15, 2020	SELL	$10.11 - $14.04 $130,449 - $181,158	-12,903 Reduced 9.4%	124,321 $1.48 Million
Q4 2019 Feb 14, 2020	BUY	$12.06 - $16.96 $1.22 Million - $1.72 Million	101,284 Added 281.81%	137,224 $1.66 Million
Q3 2019 Nov 14, 2019	BUY	$10.41 - $14.66 $374,135 - $526,880	35,940 New	35,940 $508,000

Others Institutions Holding CORT

# of Institutions

339

Shares Held

86.5M

Call Options Held

1.27M

Put Options Held

454K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.87B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account

Voloridge Investment Management, LLC Corcept Therapeutics Inc Transaction History